Conference Date & Venue
Hyatt Regency San Francisco Downtown SOMA
Support Construction of Binaytara's Cancer Hospital in Nepal
Event Description
The 6th National Precision Oncology Summit is a CME-accredited two-day conference convening leading experts in cancer genomics, molecular diagnostics, targeted therapy, and next-generation oncology modalities. Held in San Francisco, this annual summit has established itself as one of the foremost national meetings dedicated to bridging the science of precision medicine with everyday oncology practice.
The 2026 program addresses the full precision oncology continuum — from germline cancer predisposition and biomarker-driven therapy selection, to cutting-edge topics in antibody-drug conjugates, radioligand therapies, targeted protein degraders, RAS and small-molecule inhibitors, and off-the-shelf CAR-T and cell therapies. Dedicated molecular tumor board sessions challenge attendees with complex real-world cases, while a focused session on artificial intelligence explores how machine learning is reshaping oncology diagnostics and clinical decision-making. The summit also spotlights Binaytara's work in reducing cancer care disparities and features oral abstract presentations from emerging investigators.
This activity is designed to improve the knowledge and clinical competence of oncology professionals to critically evaluate and apply advances in precision oncology — translating the latest evidence in molecular diagnostics, targeted therapy, and novel treatment modalities into optimized, individualized patient care.
Participants will leave with actionable insights into the current precision oncology pipeline, practical frameworks for integrating genomic data into treatment decisions, and a forward-looking perspective on how AI and emerging drug classes are transforming the field.
Target Audience
- Hematologists
- Medical Oncologists
- Fellows in Medical Oncology and Hematology
- Advanced Practice Providers
- Oncology Nurses
- Oncology Pharmacists
- Other Cancer Care Professionals
Contact Us
Phone: 425-361-0029
Email: sponsorships@binaytara.org
About Binaytara
Binaytara is a leading global oncology 501(c)(3) nonprofit, dedicated to reducing cancer health disparities around the world. Founded in 2007 by Tara Shah and Dr. Binay Shah, our mission is to improve access to cancer care, enhance continuing medical education (CME), and foster implementation science research in hematology and oncology, thereby reducing the global burden of cancer.
As the largest cancer conference organizer in the US, we impact thousands of doctors and oncology/hematology practitioners who attend our conferences to stay current on cutting-edge treatments for their patients. Binaytara is an accredited CME provider committed to improving patient outcomes through high-quality, independent CME activities for physicians, pharmacists, and nurses.
As a leader in global oncology, we have partnered with local government and health organizations in Nepal to operate the only cancer hospital in Madhesh Province, deliver cervical cancer screenings, provide nurse training, and establish the first bone marrow transplant center in the country. In India, we have partnered with government institutions to establish hospice and palliative care programs in Madhya Pradesh. We are beginning construction in 2024 on a comprehensive 200-bed cancer center in Janakpur, Nepal that will dramatically improve access to cancer care in Nepal and surrounding communities.
We invite companies interested in improving equitable access to cancer care to support our efforts.